Back
Speaker illustration

undefined undefined undefined

Presentations

Assessment of three-dimensional echocardiography as a diagnostic tool for detecting chemotherapy-induced cardiotoxicity

Event: Heart Failure 2019

Topic: Cardiotoxicity of Drugs and Other Therapies

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

Access
Like
Thumbnail

The relation of obstructive sleep apnea syndrome with acute coronary syndromes

Event: Heart Failure 2019

Topic: Sleep Disorders

Session: Risk factors and prevention

Access
Like
Thumbnail

Three-dimensional ECHO in serial monitoring of patients undergoing Trastuzumab therapy

Event: Heart Failure 2019

Topic: Cardiotoxicity of Drugs and Other Therapies

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

Access
Like
Thumbnail

The role of MPV in the prediction of CAD severity

Event: Acute Cardiovascular Care 2019

Topic: Inflammation

Session: Acute Coronary Syndromes - Pathophysiology and Mechanisms, Biomarkers , Treatment, Revascularization Poster Discussant

Access
Like
Thumbnail

Comparison of methods for diagnosing Cardiotoxicity

Event: EuroEcho-Imaging 2018

Topic: 3D Echocardiography

Session: 3D Echocardiography

Access
Like
Thumbnail

Comparison of methods used to assess left ventricular ejection fraction in patients on chemotherapy

Event: EuroEcho-Imaging 2018

Topic: 3D Echocardiography

Session: 3D Echocardiography

Access
Like
Thumbnail

Variability of three-dimensional left ventricular ejection fraction in patients on chemotherapy

Event: EuroEcho-Imaging 2018

Topic: 3D Echocardiography

Session: 3D Echocardiography

Access
Like
Thumbnail

Three-dimensional ejection fraction is the most accurate method for diagnosing trastuzumab-induced cardiotoxicity

Event: EuroEcho-Imaging 2018

Topic: 3D Echocardiography

Session: 3D Echocardiography

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources